Effect of losartan and ramipril on oxidative stress and anti-oxidant status in south Indian hypertensive patients

International Journal of Pharmacology

Volumn 6, Issue 6, 2010, Pages 916-920

  Uday Kiran, V ^a   Venkat Rajaiah, N ^b   Rama Krishna, D ^c   Narsimha Reddy, Y ^a  

^a KAKATIYA UNIVERSITY   (India)

^b Mahatma Gandhi Memorial Hospital   (India)

^c MEDTRONIC INC   (United States)

Author keywords

Glutathione; Hypertension; Losartan; Malondialdehide; Oxidative stress; Ramipril; Total anti oxidant status

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; LOSARTAN; MALONALDEHYDE; RAMIPRIL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE;

EID: 77958012073     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.916.920     Document Type: Article

References (20)

1. Arthur, J.R., 2000. The glutathione peroxidases. Cell. Mol. Life Sci.,57: 1825-1835.
2. Beutler, E., O. Duron and B.M. Kelly, 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61: 882-888.
3. Blois, M.S., 1958. Antioxidant determination by the use of a stable free radical. Nature, 181: 1199-1200.
4. Domemc, A.S., W.B. Gehr and G. Siddhartha, 2006. Clinical pharmacokinetics of losartan. Clin. Pharmacokinet, 44: 797-814.
5. Elena de Cavanagh, M.V., F. Inserra, L. Ferder, C.G. Fraga, M. Elena and V. Cavanagh, 2000. Enalapril and captropril enhances glutathione-dependent antioxidant defenses in mouse tissues. Am. J. Physiology., 278: R572-R577.
6. Ferrira, I, J.W. Twisk and W. Van Mechelen, 2005. Development of fatness, fitness and lifestyle from adolescence to the age of 65 years. Arch. Intern. Med., 111: 1121-1127.
7. George, A.M., 1996. Cardiology clinic. Clin. Hyperten., 20: 203-204.
8. Gilhs, C.N., X. Chen and M.M. Merker, 1992. Lismopnl and ramiprilat protection of vascular endothelium against free radical induced functional injury. J. Pharmacol. Exp. Therap, 262: 212-216.
9. Gupta, R.M., 1996. Hypertention epidermiology in India. J. Hum. Hypertension, 10: 465-472.
10. Kearney, P.M., M. Whelton, K. Reynolds, P. Munter, P.K. Whelton and J. He, 2005. Global burden of hypertension: Analysis of worldwide data. Lancet, 365: 217-223.
11. Landmesser, U. and D.G. Harrison, 2001. Oxidative stress and vascular damage in hypertension. Coronary Artery Dis., 12: 455-461.
12. Mollanauv, H., M. Oelze and M. August 2005. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy. Arterisclerosis Thrombosis Vascular Biol, 25: 2554-2559.
13. Moore, K. and I.J. Robert, 1998. Measurement of lipid peroxidation. Free Radical Res., 28: 659-671.
14. Mueller, C.F., K. Laude, J.S. McNally and D.G. Harrison, 2005. Redox mechanisms in blood vessels. Arterioscler. Thromb Vase Biol, 2: 274-278.
15. Naidu, M.S.K., A.N. Suryakar, S.C. Swami, R.V. Katkam and K.M. Kumbar, 2007. Oxidative stress and antioxidant status in cervical cancer patients. Indian J. Clin Biochem., 22: 140-144.
16. Rees, D.D. and R.M. Palmer and S. Minced, 1989. Role of endothelial derived nitric oxide in the regulation of blood pressure. Proc. Natl. Abad Sci., 86: 3375-3378.
17. Reitman, S. and S. Frankel, 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Pathol., 28: 56-63.
18. Sies, H., 1999. Glutathione and its role in cellular functions. Free Radic. Biol. Med., 27: 916-921.
19. Solzbach, U., B. Harning, M. Jeserich and H. Just, 1997. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation, 96: 1513-1519.
20. Touzy, R.M., 2000. Oxidative stress and vascular damage in hypertension. Curr. Hypertens Rep., 2: 98-105.